New York State Common Retirement Fund
PSTX

New York State Common Retirement Fund’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

New York State Common Retirement Fund’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22,771
Closed -$219K – 3214
2024
Q4 		$219K Hold
22,771
– – ﹤0.01% 2260
2024
Q3 		$65.1K Hold
22,771
– – ﹤0.01% 2775
2024
Q2 		$66.5K Buy
22,771
+47
+0.2% +$129 ﹤0.01% 3014
2024
Q1 		$72.5K Sell
22,724
-39
-0.2% -$130 ﹤0.01% 2858
2023
Q4 		$76.5K Sell
22,763
-17,966
-44% -$46.3K ﹤0.01% 2846
2023
Q3 		$96.9K Buy
40,729
+729
+2% +$1.53K ﹤0.01% 2739
2023
Q2 		$70.4K Buy
+40,000
New +$102K ﹤0.01% 3046
2022
Q3 		– Sell
-307
Closed -$1K – 3487
2022
Q2 		$1K Sell
307
-11,665
-97% -$32.4K ﹤0.01% 3433
2022
Q1 		$54K Hold
11,972
– – ﹤0.01% 3154
2021
Q4 		$82K Sell
11,972
-8,709
-42% -$59.3K ﹤0.01% 3130
2021
Q3 		$151K Buy
20,681
+6,225
+43% +$53.4K ﹤0.01% 3010
2021
Q2 		$145K Sell
14,456
-6,244
-30% -$55.9K ﹤0.01% 3138
2021
Q1 		$198K Buy
20,700
+8,600
+71% +$84.3K ﹤0.01% 2835
2020
Q4 		$133K Buy
+12,100
New +$128K ﹤0.01% 2906

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund's PSTX Position: Q1 2025 in Review

New York State Common Retirement Fund sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 22,771 shares — an estimated $219K sold.

New York State Common Retirement Fund first reported a position in PSTX in Q4 2020 and held it in 14 quarters. The position peaked at $219K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • New York State Common Retirement Fund reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 22,771 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $219K.
  • New York State Common Retirement Fund first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • New York State Common Retirement Fund's Poseida Therapeutics, Inc. Common Stock position peaked at $219K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on New York State Common Retirement Fund's 13F filing for Q1 2025, filed 1 May 2025.